(BPT) – Twenty-two million Americans, many of whom are children, suffer from the frightening acute attacks and long-term disabilities of chronic asthma. Millions more adults face the increasing burdens and life-altering effects of chronic obstructive pulmonary...
(BPT) – Actress Rose McGowan, best known for her leading role in the TV series, Charmed, is sharing her story in a new leading role: raising awareness for idiopathic pulmonary fibrosis, or IPF. After her father was diagnosed with IPF, she became determined to...
View Slideshow Spencer A Brown / SFBT file 2007 Theravance Inc.South San FranciscoDrug: Anoro Ellipta.AKA: Umeclidinium and vilanterol.Indication: Chronic obstructive pulmonary disorder.Date: Dec. 19.Capping an amazing drug approval year for Rick Winningham-led...
Nursing Center – Healthday ArticleNursing Center Home > Healthday Article FDA Approves New Drug to Treat COPD Inhaled medication combines umeclidinium and vilanterol WEDNESDAY, Dec. 18, 2013 (HealthDay News) — A new inhaled drug to treat chronic...
Click here to learn how to advertise on this site and for ad rates. Disease Author: Staff Editor Last Updated: Dec 17, 2013 – 11:42:27 AM (HealthNewsDigest.com) – Joe Sisson, M.D., a University of Nebraska Medical Center clinician-scientist, was part of an...
Dec 19, 2013, 11:15am PST Enlarge Spencer A Brown / SFBT file 2007 Theravance and GSK won FDA approval Wednesday of their second new COPD drug this year. Theravance Inc. will pay partner GlaxoSmithKline plc $30 million after regulatory approval Wednesday of a...
RSS Error: A feed could not be found at `http://www.scoop.it/t/pulmonaryrehabnews/rss.xml`; the status code is `404` and content-type is `text/html;charset=UTF-8`
